TITAN PHARMACEUTICALS INC Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Titan Pharmaceuticals Inc quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Titan Pharmaceuticals Inc Return On Equity for the quarter ending June 30, 2024 was -87.9 %, a 90.7% increase year-over-year.
  • Titan Pharmaceuticals Inc annual Return On Equity for 2023 was -166 %, a 25% increase from 2022.
  • Titan Pharmaceuticals Inc annual Return On Equity for 2022 was -221 %, a 97.5% decline from 2021.
  • Titan Pharmaceuticals Inc annual Return On Equity for 2021 was -112 %, a 85.5% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -166 +55.2 +25% Jan 1, 2023 Dec 31, 2023
2022 -221 -109 -97.5% Jan 1, 2022 Dec 31, 2022
2021 -112 +659 +85.5% Jan 1, 2021 Dec 31, 2021
2020 -770 +4.47K +85.3% Jan 1, 2020 Dec 31, 2020
2019 -5.24K -4.88K -1374% Jan 1, 2019 Dec 31, 2019
2018 -355 -107 -43% Jan 1, 2018 Dec 31, 2018
2017 -248 -288 -724% Jan 1, 2017 Dec 31, 2017
2016 39.8 +244 Jan 1, 2016 Dec 31, 2016
2015 -204 -158 -338% Jan 1, 2015 Dec 31, 2015
2014 -46.6 -707 -107% Jan 1, 2014 Dec 31, 2014
2013 661 +598 +955% Jan 1, 2013 Dec 31, 2013
2012 62.6 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.